InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
50%
T+90 mean return
+1.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Gould Robert J, Director. Officer active across 1 company, notably Fulcrum Therapeutics, Inc.. Aggregated, 11 disclosures have been published. Split: 0 buy · 7 sells. Total volume traded: €946k. Activity tracked since 1 April 2022. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations11 total
15,000 shares@ US$10.87267.8% of flowCommon StockSEC:0001193125-26-037606
15,000 shares@ US$10.72387.6% of flowCommon StockSEC:0001193125-26-037573
15,000 shares@ US$10.87260.031% mcap7.8% of flowCommon StockSEC:0001193125-26-037606:0
15,000 shares@ US$10.72380.030% mcap7.6% of flowCommon StockSEC:0001193125-26-037573:0
15,000 shares@ US$11.87260.034% mcap8.5% of flowCommon StockSEC:0001193125-26-004572:0
15,000 shares@ US$11.87268.5% of flowCommon StockSEC:0001193125-26-004572
6,766 shares@ US$15.005.0% of flowCommon StockSEC:0000899243-23-001803:0
71,435 shares@ US$7.840.12% mcap29.4% of flowCommon StockSEC:0000899243-22-021530:0
16,689 shares@ US$7.840.027% mcap6.8% of flowCommon StockSEC:0000899243-22-021250:0
5,631 shares@ US$7.840.0091% mcap2.3% of flowCommon StockSEC:0000899243-22-014438:0
34,464 shares@ US$7.840.055% mcap13.7% of flowCommon StockSEC:0000899243-22-013881:0
11 of 11 declarations
About Gould Robert J
Robert J. Gould is a Director at Fulcrum Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. Robert brings his expertise in biotechnology to help Fulcrum innovate and grow in the market.
